Adhesion molecules as prognostic markers in pancreatic adenocarcinoma

Journal of Surgical Oncology

Volumn 96, Issue 5, 2007, Pages 419-423

  Torer, Nurkan ^a   Kayaselcuk, Fazilet ^a   Nursal, Tarik Zafer ^a   Yildirim, Sedat ^a   Tarim, Akin ^a   Noyan, Turgut ^a   Karakayali, Hamdi ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Adenocarcinoma; E cadherin; Ezrin; Moesin; Pancreatic

Indexed keywords

CELL ADHESION MOLECULE; EZRIN; MEMBRANE PROTEIN; MOESIN; RADIXIN; TUMOR MARKER; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CELL MIGRATION; CELL MOTILITY; CLINICAL ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MALE; METASTASIS; PANCREAS ADENOCARCINOMA; PERINEUM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 34948857411     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20654     Document Type: Article

References (19)

1. Greenlee RT, Murray T, Bolden S, et al.: Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
2. Tempia-Caliera AA, Horvath LZ, Zimmermann A, et al.: Adhesion molecules in human pancreatic cancer. J Surg Oncol 2002;79:93-100.
3. Hunter KW: Ezrin, a key component in tumor metastasis. Trends Mol Med 2004;10:201-204.
4. Akisawa N, Nishimori I, Iwamura T, et al.: High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun 1999;258:395-400.
5. Li YJ, Ji XR: Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer. World J Gastroenterol 2003;9:368-372.
6. Joo YE, Rew JS, Park CS, et al.: Expression of E-cadherin, alpha-and beta-catenins in patients with pancreatic adenocarcinoma. Pancreatology 2002;2:129-137.
7. Watanabe I, Hasebe T, Sasaki S, et al.: Advanced pancreatic ductal cancer: Fibrotic focus and beta-catenin expression correlate with outcome. Pancreas 2003;26:326-333.
8. Takamura M, Sakamoto M, Ino Y, et al.: Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 2003;94:425-430.
9. Ringel J, Jesnowski R, Schmidt C, et al.: CD44 in normal human pancreas and pancreatic carcinoma cell lines. Teratog Carcinog Mutagen 2001;21:97-106.
10. Martin TA, Harrison G, Mansel RE, et al.: The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 2003;46:165-186.
11. Pujuguet P, Del Maestro L, Gautreau A, et al.: Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 2003;14:2181-2191. Epub 2003 Feb 6.
12. Yu Y, Khan J, Khanna C, et al.: Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004;10:175-181. Epub 2004 Jan 4
13. Makitie T, Carpen O, Vaheri A, et al.: Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci 2001;42:2442-2449.
14. Ilmonen S, Vaheri A, Asko-Seljavaara S, et al.: Ezrin in primary cutaneous melanoma. Mod Pathol 2005;18:503-510.
15. Tynninen O, Carpen O, Jaaskelainen J, et al.: Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol 2004;30:472-477.
16. Khanna C, Khan J, Nguyen P, et al.: Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 2001;61:3750-3759.
17. Moilanen J, Lassus H, Leminen A, et al.: Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecol Oncol 2003;90:273-281.
18. Kobayashi H, Sagara J, Kurita H, et al: Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma. Clin Cancer Res 2004;10:572-580.
19. Ozawa M, Baribault H, Kemler R: The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989;8:1711-1717.